Bosh sahifaIDXX • NASDAQ
IDEXX Laboratories, Inc.
511,78 $
Seans yopilganidan keyin:
511,78 $
(0,00%)0,00
Yopilgan:27-sen, 20:00:00 (GMT-4) · USD · NASDAQ · Ogohlantirish
AksiyalarAQSH qimmatli qogʻoziBosh shtabi: AQSH
Yopilish kursi
509,03 $
Kunlik diapazon
509,47 $ - 518,97 $
Yillik diapazon
372,50 $ - 583,39 $
Bozor kapitalizatsiyasi
42,12 mlrd USD
Oʻrtacha hajm
370,78 ming
Narx/foyda
50,73
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(USD)iyn, 2024Y/Y qiyosi
Daromad
1,00 mlrd6,35%
Joriy xarajat
293,86 mln6,20%
Sof foyda
203,30 mln-9,34%
Sof foyda marjasi
20,26-14,73%
Har bir ulushga tushum
3,0213,11%
EBITDA
357,49 mln10,34%
Amaldagi soliq stavkasi
21,52%
Jami aktivlari
Jami passivlari
(USD)iyn, 2024Y/Y qiyosi
Naqd pul va qisqa investitsiyalar
401,59 mln202,32%
Jami aktivlari
3,41 mlrd18,95%
Jami passivlari
1,83 mlrd3,25%
Umumiy kapital
1,58 mlrd
Tarqatilgan aksiyalar
82,31 mln
Narxi/balansdagi bahosi
26,57
Aktivlardan daromad
24,03%
Kapitaldan daromad
30,77%
Naqd pulning sof oʻzgarishi
(USD)iyn, 2024Y/Y qiyosi
Sof foyda
203,30 mln-9,34%
Operatsiyalardan naqd pul
248,31 mln23,96%
Sarmoyadan naqd pul
-32,91 mln-19,79%
Moliyadan naqd pul
-210,24 mln-39,20%
Naqd pulning sof oʻzgarishi
4,16 mln-80,64%
Boʻsh pul
254,28 mln48,34%
Haqida
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses. In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO. Wikipedia
Tashkil etilgan
19-dek, 1983
Xodimlar soni
11 000
Qidiruv
Qidiruv maydonini tozalash
Qidiruvni yopish
Google ilovalari
Asosiy menyu